Automated insulin delivery for hospitalized adults with unstable blood sugar
Automated Insulin Delivery for INpatients With DysGlycemia (AIDING)
This project tests whether an automated insulin delivery device plus continuous glucose monitoring helps hospitalized adults with diabetes keep their blood sugar in a safe range.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11318956 on NIH RePORTER |
What this research studies
You would wear a continuous glucose monitor and a tubeless automated insulin delivery device while admitted to the hospital, and the device would adjust insulin based on your glucose readings. The study compares this approach to usual inpatient care with multiple daily insulin injections and standard glucose checks. Researchers will test remote monitoring for patients under isolation, methods to confirm CGM accuracy, and how hospital staff interact with the technology. The trial aims to include people often excluded from other studies, such as those with type 1 diabetes or steroid-induced high blood sugar.
Who could benefit from this research
Good fit: Adults age 21 and older who are hospitalized with uncontrolled or unstable diabetes (including type 1, type 2, or steroid-induced hyperglycemia) are the most appropriate candidates.
Not a fit: People younger than 21, those not hospitalized, patients who require continuous IV insulin, or those who cannot use wearable sensors or pumps are unlikely to be eligible or benefit.
Why it matters
Potential benefit: If successful, this could improve blood-sugar control during hospital stays, reduce dangerous high and low glucose events, and make insulin management in the hospital safer and more convenient.
How similar studies have performed: Previous single-center European trials have shown improved inpatient glucose control with automated insulin delivery, but broader reproducibility, scalability, and remote-use approaches remain unproven.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Pasquel, Francisco J — Emory University
- Study coordinator: Pasquel, Francisco J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.